Rallybio CFO Lieber goes part-time Sept 15, $420k salary, no bonus, until Avenzo merger closes

Rallybio Corp

CFO Jonathan Lieber transitions to part-time effective Sept 15, 2026; retains CFO and Principal Financial Officer roles.
Base salary set at $420,000 annualized; no annual bonus for 2026 or any later year while employed.
Employment terminates upon closing of pending merger with Avenzo Therapeutics (agreement dated May 31, 2026).
Severance per existing employment agreement; equity awards remain eligible to vest per merger terms.
Lieber may engage in other business activities while part-time, subject to no conflicts.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.